Skip to content

Author

A. Naz

We have 2 of 75 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Temporal trends and projections of hypertension with hyperlipidemia-related mortality among US adults, 2000-2035: Insights from CDC WONDER database.

BACKGROUND Hypertension and hyperlipidemia are highly prevalent cardiometabolic disorders and major contributors to cardiovascular morbidity and mortality. These conditions frequently coexist and synergistically increase cardiovascular risk through mechanisms including endothelial dysfunction, vascular inflammation, an...

Saifullah Khan, Muhammad Vazaym, Muhammad Jawad et al. · 0 citations
Meta-analysis Open access Sep 2026

Efficacy and safety of zilebesiran in adults with hypertension: a systematic review and meta-analysis of randomized controlled trials

Overall, zilebesiran produced significant and consistent BP reductions, especially in ambulatory measures, with a favorable safety profile, and builds on previous meta-analyses that included only 2 RCTs; this updated analysis reflects the need for novel therapeutic options.

Muhammad Hussain, Muhammad Hassan, Asharib Sohaib et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.